Life Science Investing Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
Life Science Investing Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
Life Science Investing Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
